Despite high R&D spending and cash burn, Moderna aims for breakeven by 2028, driven by new vaccine opportunities. Explore ...

Mergers and acquisitions grabbed the spotlight in the biotech sector this week after Jazz Pharmaceuticals JAZZ announced an ...

The widespread availability of vaccines is preventing severe illness and death. Those same vaccines are constantly being updated to cover current variants, much like the flu shot. Along with that, the ...

Gov. Ron DeSantis spoke in Tampa this week about vaccine mandates, warning that key protections for Floridians could soon ...

Patent Trial and Appeal Board (PTAB) docket entries indicate that the PTAB has invalidated all challenged claims of Moderna’s ...

As part of a global web of patent litigation over COVID-19 vaccines and mRNA technology, Pfizer and its partner BioNTech ...

Antimicrobial resistance (AMR) is a critical challenge to global public health, with the livestock sector playing a ...

Federal legal protections added in the 1980s to shield vaccine manufacturers from most lawsuits would be waived any time a ...

Florida first lady Casey DeSantis called out the CDC for continuing to recommend COVID-19 vaccines for children beginning at ...

Moderna, Inc. (NASDAQ:MRNA) shares rose for a second day on Wednesday, adding 15.94 percent to finish at $35.21 apiece as ...

The mRNA vaccines that helped to end the COVID pandemic — and stoked a considerable amount of vaccine skepticism and ...

Measles is a disease that should be a relic of the past with vaccination. But now a child is dead from a disease that is entirely preventable.